Clinical Trial: **Efficacy and Safety of Vonoprazan-Based Bismuth-Free Dual Therapy versus Keverprazan-Based Bismuth-Free Dual Therapy for Helicobacter pylori Eradication: A Multicenter, Open-Label, Randomized Controlled Trial** (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled '**Efficacy and Safety of Vonoprazan-Based Bismuth-Free Dual Therapy versus Keverprazan-Based Bismuth-Free Dual Therapy for Helicobacter pylori Eradication: A Multicenter, Open-Label, Randomized Controlled Trial**'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129861

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: NanJing First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329562

Published by HT Digital Content Services with permission from Health Daily Digest....